14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CTRE vs SBRA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.66 (22.3x Forward P/E, 66.2% operating margin), whereas SBRA carries 56.4/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin).
Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (56.4/100 HOLD vs. CTRE 46.6/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (66.2% vs. 18.4% operating margin) and revenue trajectory (+33.2% vs. +31.6% YoY).
Competes within the REIT - Healthcare Facilities value chain with $5.4B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment31.2% of Rev ($288M)
90D Engineering Disclosures0 Published
Investor FAQ CTRE vs SBRA Key Questions & Quantitative Answers
As of Nov 16, 2026, CareTrust REIT, Inc (CTRE) is the stronger overall head-to-head candidate over Sabra Healthcare REIT, Inc. (SBRA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). CTRE carries a Unified Composite Score of 46.6/100 (HOLD) at $37.66 (22.3x Forward P/E, 66.2% operating margin), whereas SBRA carries 56.4/100 (HOLD) at $20.42 (28.2x Forward P/E, 18.4% operating margin). Composite vs. Pillar Nuance: While SBRA currently prints a higher short-term Unified Composite Score (56.4/100 HOLD vs. CTRE 46.6/100 HOLD), CTRE captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (66.2% vs. 18.4% operating margin) and revenue trajectory (+33.2% vs. +31.6% YoY).
CTRE leads the Growth & Scale pillar: CTRE posts +33.2% YoY revenue growth and -0.8% YoY earnings growth on $615M TTM revenue (95.7% gross margin, 66.2% operating margin), compared with SBRA at +31.6% YoY revenue growth and +22.2% YoY earnings growth on $924M TTM revenue (49.6% gross margin, 18.4% operating margin). Across the 5-period historical trajectory (Q3 '25 to Q3 '26), CTRE cumulative revenue shifted +28.6% while SBRA shifted +31.6%. In operating R&D and SG&A reinvestment, CTRE deploys 29.5% of Rev ($182M) (0 90-day corporate R&D disclosures) versus 31.2% of Rev ($288M) (0 disclosures) for SBRA.
CTRE screens cheaper on headline valuation multiples. CTRE trades at 22.3x Forward P/E, 24.0x Trailing P/E, 1.26x PEG, and 18.6x EV/Revenue (78.8% FCF margin), whereas SBRA trades at 28.2x Forward P/E, 76.2x Trailing P/E, 5.28x PEG, and 8.4x EV/Revenue (43.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CTRE (7.7% ROE) versus SBRA (2.5% ROE) capital efficiency.
In options market volatility and institutional positioning, CTRE carries 24.7% implied volatility (10th %ile, Compressed (<25th %ile)), a 6.12x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.14β · 28% Vol realized risk). By comparison, SBRA carries 21.6% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.11x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.01β · 31% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.